Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)
- PMID: 9135032
- DOI: 10.1021/jm960803q
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)
Abstract
A series of sulfonamide-containing 1,5-diarylpyrazole derivatives were prepared and evaluated for their ability to block cyclooxygenase-2 (COX-2) in vitro and in vivo. Extensive structure-activity relationship (SAR) work was carried out within this series, and a number of potent and selective inhibitors of COX-2 were identified. Since an early structural lead (1f, SC-236) exhibited an unacceptably long plasma half-life, a number of pyrazole analogs containing potential metabolic sites were evaluated further in vivo in an effort to identify compounds with acceptable pharmacokinetic profiles. This work led to the identification of 1i (4-[5-(4-methylphenyl)-3-(trifluoromethyl)- H-pyrazol-1-yl]benzenesulfonamide, SC-58635, celecoxib), which is currently in phase III clinical trials for the treatment of rheumatoid arthritis and osteoarthritis.
Similar articles
-
Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.J Med Chem. 2003 Jul 31;46(16):3463-75. doi: 10.1021/jm030765s. J Med Chem. 2003. PMID: 12877584
-
In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.J Med Chem. 2004 Feb 12;47(4):792-804. doi: 10.1021/jm020545z. J Med Chem. 2004. PMID: 14761182
-
3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.Bioorg Med Chem Lett. 2004 Dec 20;14(24):6049-52. doi: 10.1016/j.bmcl.2004.09.073. Bioorg Med Chem Lett. 2004. PMID: 15546727
-
Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?J Rheumatol Suppl. 1999 Apr;56:31-6. J Rheumatol Suppl. 1999. PMID: 10225538 Review.
-
Outcome of specific COX-2 inhibition in rheumatoid arthritis.J Rheumatol Suppl. 1997 Jul;49:9-14. J Rheumatol Suppl. 1997. PMID: 9249645 Review.
Cited by
-
Anti-inflammatory and antimicrobial activities of novel pyrazole analogues.Saudi J Biol Sci. 2016 Sep;23(5):614-20. doi: 10.1016/j.sjbs.2015.07.005. Epub 2015 Jul 29. Saudi J Biol Sci. 2016. PMID: 27579011 Free PMC article.
-
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.Mol Cancer. 2006 May 18;5:19. doi: 10.1186/1476-4598-5-19. Mol Cancer. 2006. PMID: 16707021 Free PMC article.
-
Synthesis, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities, and molecular docking studies of a novel compound based on combination of flurbiprofen and isoniazide.RSC Adv. 2020 May 20;10(33):19346-19352. doi: 10.1039/d0ra02339f. eCollection 2020 May 20. RSC Adv. 2020. PMID: 35515452 Free PMC article.
-
Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation.Br J Pharmacol. 1999 Oct;128(4):853-9. doi: 10.1038/sj.bjp.0702866. Br J Pharmacol. 1999. PMID: 10556918 Free PMC article.
-
Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids.Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15280-5. doi: 10.1073/pnas.96.26.15280. Proc Natl Acad Sci U S A. 1999. PMID: 10611376 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical
Molecular Biology Databases
Research Materials
Miscellaneous